192 related articles for article (PubMed ID: 31279828)
1. Utilization of herpesviridae as recombinant viral vectors in vaccine development against animal pathogens.
Kamel M; El-Sayed A
Virus Res; 2019 Sep; 270():197648. PubMed ID: 31279828
[TBL] [Abstract][Full Text] [Related]
2. Recombinant viruses as vaccines against viral diseases.
Souza AP; Haut L; Reyes-Sandoval A; Pinto AR
Braz J Med Biol Res; 2005 Apr; 38(4):509-22. PubMed ID: 15962176
[TBL] [Abstract][Full Text] [Related]
3. The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors.
Kamel MS; Munds RA; Verma MS
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003300
[TBL] [Abstract][Full Text] [Related]
4. Recombinant viruses as vectors for mucosal immunity.
Morrow CD; Novak MJ; Ansardi DC; Porter DC; Moldoveanu Z
Curr Top Microbiol Immunol; 1999; 236():255-73. PubMed ID: 9893364
[TBL] [Abstract][Full Text] [Related]
5. New approaches to the development of virus vaccines for veterinary use.
Yamanouchi K; Barrett T; Kai C
Rev Sci Tech; 1998 Dec; 17(3):641-53. PubMed ID: 9850535
[TBL] [Abstract][Full Text] [Related]
6. Vaxvec: The first web-based recombinant vaccine vector database and its data analysis.
Deng S; Martin C; Patil R; Zhu F; Zhao B; Xiang Z; He Y
Vaccine; 2015 Nov; 33(48):6938-46. PubMed ID: 26403370
[TBL] [Abstract][Full Text] [Related]
7. Recombinant viral vector vaccines for the veterinary use.
Yokoyama N; Maeda K; Mikami T
J Vet Med Sci; 1997 May; 59(5):311-22. PubMed ID: 9192350
[TBL] [Abstract][Full Text] [Related]
8. Efficient heterologous antigen gene delivery and expression by a replication-attenuated BoHV-4-based vaccine vector.
Capocefalo A; Mangia C; Franceschi V; Jacca S; van Santen VL; Donofrio G
Vaccine; 2013 Aug; 31(37):3906-14. PubMed ID: 23830977
[TBL] [Abstract][Full Text] [Related]
9. Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.
Bischof GF; Magnani DM; Ricciardi M; Shin YC; Domingues A; Bailey VK; Gonzalez-Nieto L; Rakasz EG; Watkins DI; Desrosiers RC
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592531
[TBL] [Abstract][Full Text] [Related]
10. Vector-based genetically modified vaccines: Exploiting Jenner's legacy.
Ramezanpour B; Haan I; Osterhaus A; Claassen E
Vaccine; 2016 Dec; 34(50):6436-6448. PubMed ID: 28029542
[TBL] [Abstract][Full Text] [Related]
11. Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer.
Bailer SM; Funk C; Riedl A; Ruzsics Z
Virus Genes; 2017 Oct; 53(5):741-748. PubMed ID: 28634751
[TBL] [Abstract][Full Text] [Related]
12. Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines.
Tang N; Zhang Y; Shen Z; Yao Y; Nair V
CRISPR J; 2021 Aug; 4(4):477-490. PubMed ID: 34406035
[TBL] [Abstract][Full Text] [Related]
13. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
15. Applications and challenges of multivalent recombinant vaccines.
Naim HY
Hum Vaccin Immunother; 2013 Mar; 9(3):457-61. PubMed ID: 23249651
[TBL] [Abstract][Full Text] [Related]
16. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
Taylor J; Paoletti E
Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
[TBL] [Abstract][Full Text] [Related]
17. Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform.
Poulet H; Minke J; Pardo MC; Juillard V; Nordgren B; Audonnet JC
Vaccine; 2007 Jul; 25(30):5606-12. PubMed ID: 17227690
[TBL] [Abstract][Full Text] [Related]
18. Swinepox virus as a vaccine vector for swine pathogens.
Tripathy DN
Adv Vet Med; 1999; 41():463-80. PubMed ID: 9890036
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.
Okoli A; Okeke MI; Tryland M; Moens U
Viruses; 2018 Jan; 10(1):. PubMed ID: 29361752
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases.
Duan Z; Xu H; Ji X; Zhao J
Future Microbiol; 2015; 10(8):1307-23. PubMed ID: 26234909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
